h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
IITi001-A
Registration Summary
:
A
P
E
C
29.2
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
IITi001-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
IITi001-A (RRID:CVCL_VD72)
Alternative name(s)
29.2
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
7th February 2018
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Technion - Israel Institute of Technology (IIT)
External Databases
Cellosaurus
CVCL_VD72
Wikidata
Q54897448
General Information
Publications
Schick R et al. Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy. PloS one. 2018;13(10):e0205719.
Eisen B et al. Generation of Duchenne muscular dystrophy patient-specific induced pluripotent stem cell line lacking exons 45-50 of the dystrophin gene (IITi001-A). Stem cell research. 2018 May;29:111-114.
D'Amario D et al. Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine. Journal of clinical medicine. 2018 Sep 19;7(9).
Echigoya Y et al. Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges. Journal of personalized medicine. 2018 Dec 7;8(4).
Piga D et al. Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies. Therapeutic advances in neurological disorders. 2019;12:1756286419833478.
Eisen B et al. Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients. Journal of cellular and molecular medicine. 2019 Mar;23(3):2125-2135.
Casamassa A et al. A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15. International journal of molecular sciences. 2020 Mar 9;21(5).
Rovina D et al. "Betwixt Mine Eye and Heart a League Is Took": The Progress of Induced Pluripotent Stem-Cell-Based Models of Dystrophin-Associated Cardiomyopathy. International journal of molecular sciences. 2020 Sep 23;21(19).
Jimenez-Vazquez EN et al. SNTA1 gene rescues ion channel function and is antiarrhythmic in cardiomyocytes derived from induced pluripotent stem cells from muscular dystrophy patients. eLife. 2022 Jun 28;11.
Willi L et al. Bioenergetic and Metabolic Impairments in Induced Pluripotent Stem Cell-Derived Cardiomyocytes Generated from Duchenne Muscular Dystrophy Patients. International journal of molecular sciences. 2022 Aug 29;23(17).
Eisen Binyamin et al. Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients’ Induced Pluripotent Stem-Cell-Derived Cardiomyocytes. International Journal of Molecular Sciences. 2023-05-12.
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.